# HS 293719 Other Than Somatotropin global trade data overview...

Reported global trade in other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts reached $32.9B in 2024, with five-year annual growth of +31.7%.

## Annual trade evidence

| Year | Global trade | Year-on-year growth | 3-year growth |
| --- | --- | --- | --- |
| 2013 | $6.5B | +16.3% | +17.2% |
| 2014 | $7.3B | +13.2% | +14.6% |
| 2015 | $6.4B | -12.9% | +4.6% |
| 2016 | $5.8B | -8.4% | -3.3% |
| 2017 | $8.4B | +44.3% | +4.8% |
| 2018 | $6.7B | -20.6% | +1.6% |
| 2019 | $8.3B | +24.5% | +12.6% |
| 2020 | $10.5B | +25.7% | +7.5% |
| 2021 | $12.0B | +15.1% | +21.7% |
| 2022 | $13.3B | +10.8% | +17% |
| 2023 | $23.0B | +72.1% | +30% |
| 2024 | $32.9B | +43.5% | +39.9% |

## Leading buyer markets

| Buyer market | Latest imports | 5-year growth | Suppliers |
| --- | --- | --- | --- |
| USA | $16.4B | +61.1% | 35 |
| Italy | $9.1B | +77.8% | 26 |
| Germany | $2.3B | +17.3% | 34 |
| China | $2.2B | +36.6% | 26 |
| France | $734.1M | -5.4% | 28 |
| Denmark | $718.1M | +233% | 23 |
| Austria | $651.9M | -26.4% | 16 |
| Belgium | $118.2M | +38.6% | 21 |
| Spain | $107.6M | +40.5% | 21 |
| Switzerland, Liechtenstein | $101.4M | -21.4% | 25 |
| Russia | $75.9M | +18.7% | 17 |
| Japan | $57.3M | -13.3% | 21 |

_Source: reported merchandise trade data. Updated 2026-08-14._